Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study
- 28 February 1997
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (2) , 312-315
- https://doi.org/10.1016/s0959-8049(96)00372-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Potential Role of Oral Anthracyclines in Older Patients with CancerDrugs & Aging, 1994
- Phase II study of an oral combination of doxifluridine, prednimustine and idarubicin (FUPRIDA) for first line treatment of advanced breast cancerAnnals of Oncology, 1993
- Comparison of cytotoxicity in heart cells and tumor cells exposed to DNA intercalating agents in vitroAnti-Cancer Drugs, 1991
- Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1991
- Combination of Idarubicin and Cyclophosphamide Administered Orally in Untreated Postmenopausal Breast Cancer PatientsOncology, 1991
- Comparative Phase II Study of Idarubicin versus Doxorubicin in Advanced Breast CancerOncology, 1990
- A prospective randomized trial of doxorubicinversus idarubicin in the treatment of advanced breast cancerCancer, 1989
- A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancerCancer, 1983
- Reporting results of cancer treatmentCancer, 1981